Grants and Contracts per year
- 1 - 50 out of 92 results
Search results
-
Active
-
Strength and Muscle Related Outcomes for Nutrition and Lung Function in CF (STRONG-CF)
Jaeb Center for Health Research Foundation Incorporated
4/7/23 → 12/31/28
Project: Research project
-
A Phase 3, Open-Label Study Evaluating the Longterm Safety and Efficacy of VX-121 Combination Therapy in Subjects with Cystic Fibrosis
Wurth, M., Anstead, M. & Danov, Z.
6/16/22 → 4/3/24
Project: Research project
-
Therapeutic Development Center FY24
Wurth, M., Anstead, M., Danov, Z., Kanga, J., Kuhn, R. & Ramdial, F.
4/1/22 → 3/31/24
Project: Research project
-
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-121 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for F508del or Heterozygous for F508del and a Gating (F/G) or Residual Function (F/R
Wurth, M., Anstead, M., Garrett, N. & Danov, Z.
9/1/21 → 5/25/24
Project: Research project
-
A Prospective Study Evaluating Maternal and FetaL Outcomes in the ERa of ModulatorS (MAYFLOWERS)
Anstead, M., Danov, Z. & Kanga, J.
Seattle Childrens Research Institute
4/1/21 → 2/15/24
Project: Research project
-
A Prospective Study to Evaluate Biological and Clinical Effects of Significantly Corrected CFTR Function (The PROMISE Study)
Wurth, M., Anstead, M. & Pancham, K.
Seattle Childrens Research Institute
11/1/18 → 6/14/24
Project: Research project
-
Finished
-
Therapeutic Development Center FY22
Wurth, M., Anstead, M., Danov, Z., Kanga, J. & Kuhn, R.
4/1/22 → 3/31/23
Project: Research project
-
-
Cystic Fibrosis Care Center Program 2020-2021 (Adult Portion)
7/1/20 → 6/30/21
Project: Research project
-
A Master Protocol to Test the Impact of Discontinuing Chronic Therapies in People with Cystic Fibrosis on Highly Effective CFTR Modulator Therapy (SIMPLIFY)
Danov, Z., Anstead, M., Garrett, N., Wilson, E. & Pancham, K.
Seattle Childrens Research Institute
1/1/20 → 2/8/23
Project: Research project
-
VS18-445-113: A Phase 3, Open-label Study Evaluating the Long-term Safety of VX-445 Combination Therapy in Subjects with Cystic Fibrosis
Danov, Z., Anstead, M. & Pancham, K.
7/22/19 → 5/27/23
Project: Research project
-
VX18-445-104: A Phase 3, Randomized, Double-Blind, Controlled Study Evaluating the Efficacy and Safety of VX-445 Comination Therapy in Subject with Cystic Fibrosis Who Are Heterozygous for the F508del Mutation and a Gating or Residual Function Mutation
Danov, Z., Anstead, M. & Pancham, K.
7/8/19 → 6/18/21
Project: Research project
-
A Phase 2, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of VX-561 in Subjects Aged 18 Years and Older With Cystic Fibrosis
Pancham, K. & Anstead, M.
3/14/19 → 1/29/21
Project: Research project
-
A Phase 2, Randomized, Double-blind, Controlled Study to Evaluate the Safety and Efficacy of VX-121 Combination Therapy in Subjects Aged 18 Years and Older with Cystic Fibrosis
Pancham, K. & Anstead, M.
1/25/19 → 12/6/20
Project: Research project
-
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Therapy in Subjects with Cystic Fibrosis Who are Heterozygous for the F508del Mutation and a Minimal Function Mutation (F/MF) VX17-659-102
Pancham, K. & Anstead, M.
3/27/18 → 3/20/19
Project: Research project
-
A Real-World Chart Review Study on ORKAMBI Use in the United States
10/17/16 → 10/31/18
Project: Research project
-
Cystic Fibrosis Center Program 2016-2017
Kanga, J., Anstead, M., Danov, Z. & Pancham, K.
7/1/16 → 6/30/17
Project: Research project
-
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of N91115 to Evaluate Efficacy and Safety in Patients with Cystic Fibrosis who are Homozygous for the F508del-CFTR Mutation and Being Treated with lumacaftor/ivacaftor (ORKAMBI)
Anstead, M., Danov, Z., Kanga, J. & Tupayachi Ortiz, M.
Nivalis Therapeutics Incorporated
9/30/15 → 8/30/17
Project: Research project
-
-
CFFT TDN Spring Meeting
Anstead, M. & Danov, Z.
Cystic Fibrosis Foundation Therapeutics Incorporated
2/1/15 → 7/31/15
Project: Research project
-
Additional Research Coordinator (ARC) Award FY 17
Pancham, K. & Anstead, M.
Cystic Fibrosis Foundation Therapeutics Incorporated
12/1/14 → 11/30/17
Project: Research project
-
University of Kentucky ARC Award
Cystic Fibrosis Foundation Therapeutics Incorporated
12/1/14 → 11/30/15
Project: Research project
-
Additional Research Coordinator (ARC) Award
Cystic Fibrosis Foundation Therapeutics Incorporated
12/1/14 → 11/30/16
Project: Research project
-
-
Therapeutic Development Center FY 2018
Pancham, K., Anstead, M., Danov, Z. & Kuhn, R.
1/1/14 → 12/31/18
Project: Research project
-
Therapeutics Development Network 2014-2015
Anstead, M., Danov, Z., Kanga, J. & Kuhn, R.
Cystic Fibrosis Foundation Therapeutics Incorporated
1/1/14 → 12/31/15
Project: Research project
-
Therapeutic Development Center
Pancham, K., Anstead, M., Danov, Z. & Kuhn, R.
Cystic Fibrosis Foundation Therapeutics Incorporated
1/1/14 → 12/31/17
Project: Research project
-
Therapeutics Development Center
Anstead, M., Danov, Z., Kuhn, R. & Tupayachi Ortiz, M.
Cystic Fibrosis Foundation Therapeutics Incorporated
1/1/14 → 12/31/16
Project: Research project
-
Therapeutic Development Center FY2020
Pancham, K., Anstead, M., Danov, Z., Kanga, J. & Kuhn, R.
1/1/14 → 3/31/20
Project: Research project
-
Therapeutic Development Center FY2022
Wurth, M., Anstead, M., Danov, Z., Kanga, J. & Kuhn, R.
1/1/14 → 3/30/22
Project: Research project
-
Therapeutic Development Center FY2021
Pancham, K., Anstead, M., Danov, Z., Kanga, J. & Kuhn, R.
1/1/14 → 3/31/21
Project: Research project
-
Vertex 770-115 An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 years of Age or Younger With Cystic Fibrosis
11/25/13 → 11/30/15
Project: Research project
-
Proof of Principal Evaluation of IV Gallium Nitrate (Ganite) in Patients with Cystic Fibrosis
Pancham, K., Danov, Z., Kanga, J., Anstead, M. & Tupayachi Ortiz, M.
Seattle Childrens Research Institute
9/1/13 → 6/30/18
Project: Research project
-
G551D Observational Study - Expanded to Additional Genotypes and TExtended for Long-term Follow-up
Seattle Childrens Research Institute
9/1/13 → 12/31/16
Project: Research project
-
-
-
-
Cystic Fibrosis Center Program 2017-2018
Kanga, J., Anstead, M., Danov, Z. & Pancham, K.
7/1/13 → 6/30/18
Project: Research project
-
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Lumacaftor in Combination with Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, omozygous for the F508del-CFTR Mutation
Anstead, M., Danov, Z. & Kanga, J.
6/20/13 → 6/30/15
Project: Research project
-
KaloBios CF KB001A-05 A Phase 2, Randomized Double-Blind, Placebo-Controlled, Repeat-dose Study of KB001A in Subjects with Cystic Fibrosis Infected withPseudomonas Aeruginosa
Danov, Z., Anstead, M. & Kanga, J.
KaloBios Pharmaceuticals Incorporated
10/30/12 → 10/30/14
Project: Research project
-
A Long-Term Prospective Observational Safety Study of the Incidence of and Risk Factors for Fibrosing Colonopathy
Anstead, M., Danov, Z. & Kanga, J.
Seattle Childrens Research Institute
10/22/12 → 9/30/20
Project: Research project
-
KaloBios Asthma Study KB003-04 Safety, Tolerability, and Efficacy
Anstead, M., Danov, Z., Kanga, J. & Khosravi, M.
Chiltern International Incorporated
10/1/12 → 9/30/14
Project: Research project
-
VX12-770-112 / A Phase 3, Two-Arm, Rollover Study to Evaluate the Safety of Long-Term Ivacaftor Treatment in Subjects 6 Years of Age and Older
Anstead, M., Danov, Z. & Kanga, J.
9/1/12 → 8/30/14
Project: Research project